Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biotechnology company advancing precision oncology through its ...
NEW YORK (Reuters) - Usually proprietary means exclusive. But when it comes to quantitative equity models that some mutual fund managers charge a premium for, proprietary is a matter of degree. Even ...
Quantitative finance continues to debate the reliability and limits of model-driven investment strategies. Causal reasoning remains essential, but the relevant structure may itself include feedback ...